| Patent Number |
Title Of Patent |
Date Issued |
| 7626040 |
Substituted imidazole compounds as KSP inhibitors |
December 1, 2009 |
| The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses of the compounds. The compounds of the invention have t |
| 7608723 |
Indole and benzimidazole derivatives |
October 27, 2009 |
| The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the inventi |
| 7576221 |
Substituted imidazole derivatives |
August 18, 2009 |
| The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention |
| 7553854 |
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signali |
June 30, 2009 |
| Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic |
| 7521062 |
Thiosemicarbazones as anti-virals and immunopotentiators |
April 21, 2009 |
| The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by |
| 7504405 |
Mitotic kinesin inhibitors |
March 17, 2009 |
| The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of |
| 7452996 |
Substituted quinoline derivatives |
November 18, 2008 |
| The present invention relates to new substituted quinoline compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention |
| 7345046 |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
March 18, 2008 |
| Heteroaryl-fused pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional |
| 7326711 |
Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
February 5, 2008 |
| Pyridin[1,2-a]pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the pyridino[1,2-a]pyrimidinyl compounds, either alone or in combination with at least one additional thera |
| 7323570 |
Farnesyltransferase inhibitors |
January 29, 2008 |
| Substituted imidazoles and thiazoles having the formula ##STR00001## are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient. |
